Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Clinical trial NCT03367546 · TERMINATED

Trial details

NCT number: NCT03367546
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Thalassemia High Risk Hematologic Disorders Cerebral Adrenoleukodystrophy Inherited Metabolic Disorders

Start date: 2018-07-02
Primary completion: 2022-12-19
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.